Predictions
Formycon AG
Start price
Target price
Perf. (%)
€67.40
07.02.21
07.02.21
€80.00
07.02.22
07.02.22
-20.03%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.88
07.02.21
07.02.21
€5.00
07.02.22
07.02.22
-66.49%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Canopy Growth Corp
Start price
Target price
Perf. (%)
€36.00
07.02.21
07.02.21
-
07.02.22
07.02.22
-80.67%
08.02.22
08.02.22
Probably not worthwhile Investment
High risks for its business
Few uniques
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€137.50
06.02.21
06.02.21
€150.00
06.02.22
06.02.22
-67.82%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
MaxCyte Inc
Start price
Target price
Perf. (%)
€10.00
06.02.21
06.02.21
€10.00
06.02.22
06.02.22
33.00%
12.08.21
12.08.21
Capable Management
Future proof or reliable business model
Higher risks for its business
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€416.00
06.02.21
06.02.21
-
06.02.22
06.02.22
7.91%
25.05.21
25.05.21
EBIT growth >5% per year expected
Very low/no dividend yield expected
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€137.50
06.02.21
06.02.21
-
06.02.22
06.02.22
-10.00%
19.02.21
19.02.21
Could be very worthwhile Investment >20% year
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€132.95
05.02.21
05.02.21
€100.00
-10.68%
21.02.21
21.02.21
Risky Investment
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
05.02.21
05.02.21
-
31.12.21
31.12.21
0.09%
29.03.21
29.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€82.00
02.02.21
02.02.21
€85.00
01.02.24
01.02.24
-96.49%
20.12.23
20.12.23
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Innovative
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€33.80
02.02.21
02.02.21
€30.00
16.02.21
16.02.21
0.27%
02.02.21
02.02.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.24
01.02.21
01.02.21
€40.00
01.02.22
01.02.22
1.56%
01.02.22
01.02.22
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.17
01.02.21
01.02.21
€26.00
30.06.22
30.06.22
-10.17%
19.05.22
19.05.22
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€222.00
01.02.21
01.02.21
€260.00
30.03.22
30.03.22
-6.17%
09.10.21
09.10.21
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€6.91
29.01.21
29.01.21
€8.00
16.27%
06.02.21
06.02.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€37.03
29.01.21
29.01.21
€34.00
29.04.21
29.04.21
-5.94%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Inovio Pharma
Start price
Target price
Perf. (%)
€9.50
28.01.21
28.01.21
€14.00
23.16%
04.02.21
04.02.21
Risky Investment
High risks for its business
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€38.44
27.01.21
27.01.21
€45.00
27.01.22
27.01.22
-4.29%
28.01.22
28.01.22
Could be worthwhile Investment >10% per year
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€240.00
25.01.21
25.01.21
€350.00
25.01.22
25.01.22
-73.33%
26.01.22
26.01.22
Could be very worthwhile Investment >20% year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year